Skip to main content

Blueprint for Access to Innovative Healthcare Episode 2: Screening

By: 3BL Media
ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

SOURCE: Takeda

DESCRIPTION:

Takeda’s flagship Access to Medicines initiative, the Blueprint for Innovative Healthcare Access program, works with a consortium of public and private partners sharing resources and responsibility, each bringing specific strengths and expertise to address rising Non-Communicable Diseases (NCDs) challenges in underserved communities. Meet the people who are living and breathing the Blueprint in the second episode focusing on the importance of screening of NCDs of a 5-part series of our pilot program in Meru County, Kenya.

Tweet me: Meet the people who are living and breathing @Takeda's Blueprint in the second episode focusing on the importance of screening of NCDs of a 5-part series of our pilot program in Meru County, Kenya. https://bit.ly/3w5qELy

KEYWORDS: takeda, Blueprint for Access to Innovative Healthcare, NYSE: TAK

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  246.82
-10.55 (-4.10%)
AAPL  342.56
-6.65 (-1.90%)
AMD  424.39
-64.80 (-13.25%)
BAC  47.04
-1.53 (-3.15%)
GOOG  264.00
-7.02 (-2.59%)
META  560.84
-35.38 (-5.93%)
MSFT  484.52
-13.78 (-2.77%)
NVDA  125.53
-20.45 (-14.01%)
ORCL  101.19
-9.38 (-8.48%)
TSLA  345.82
-28.59 (-7.64%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.